CELLTOLERANCE Trademark

Trademark Overview

On Monday, July 22, 2024, a trademark application was filed for CELLTOLERANCE with the United States Patent and Trademark Office. The USPTO has given the CELLTOLERANCE trademark a serial number of 79408132. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Friday, August 22, 2025. This trademark is owned by MAUNA KEA TECHNOLOGIES. The CELLTOLERANCE trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Health care services for human beings, namely gastrointestinal health care services; medical care services; medical analysis services relating to the treatment of patients; medical services for the remote analysis of optical samples and diagnosis on cells; medical services relating to the collection, treatment and processing of human cells; medical assessment of health status for medical diagnostic purposes; medical diagnosis services, namely, medical diagnosis of digestive disorders; medical diagnostic and testing services in relation to digestive and gastrointestinal diseases and disorders; medicaltesting services for diagnostic or treatment purposes; health care management in the nature of developing care protocols in relation to digestive and gastrointestinal diseases and disorders; providing news and information in the field of medicine; provision of information relating to medical services; provision of medical information in the field of health; providing medical information in ...

Scientific and technological services, namely, scientific research and design services in the field of diagnostic tools for medical applications; Development of new technology on behalf of third parties in the field of biotechnology; providing information relating to medical and scientific research in the field of clinical trials; providing medical and scientific research information in the pharmaceutical field; scientific research and development in the field of pharmaceuticals and biotechnology; analyzing, assessing and reporting diagnostic test results and diagnostic or prognostic tests of residual disease to assist healthcare professionals in the clinical diagnosis of a patient, to assess the effectiveness of treatments prescribed to patients and change future treatments accordingly; medical and scientific research in the field of treatment and diagnosis of digestive and gastrointestinal diseases and disorders
celltolerance

General Information

Serial Number79408132
Word MarkCELLTOLERANCE
Filing DateMonday, July 22, 2024
Status645 - FINAL REFUSAL - MAILED
Status DateFriday, August 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkCELL TOLERANCE
Goods and ServicesHealth care services for human beings, namely gastrointestinal health care services; medical care services; medical analysis services relating to the treatment of patients; medical services for the remote analysis of optical samples and diagnosis on cells; medical services relating to the collection, treatment and processing of human cells; medical assessment of health status for medical diagnostic purposes; medical diagnosis services, namely, medical diagnosis of digestive disorders; medical diagnostic and testing services in relation to digestive and gastrointestinal diseases and disorders; medicaltesting services for diagnostic or treatment purposes; health care management in the nature of developing care protocols in relation to digestive and gastrointestinal diseases and disorders; providing news and information in the field of medicine; provision of information relating to medical services; provision of medical information in the field of health; providing medical information in the field of gastroenterology; individual medical advisory services provided to patients; medical analysis services relating to the treatment of patients; medical testing services for the diagnosis and treatment of persons
Goods and ServicesScientific and technological services, namely, scientific research and design services in the field of diagnostic tools for medical applications; Development of new technology on behalf of third parties in the field of biotechnology; providing information relating to medical and scientific research in the field of clinical trials; providing medical and scientific research information in the pharmaceutical field; scientific research and development in the field of pharmaceuticals and biotechnology; analyzing, assessing and reporting diagnostic test results and diagnostic or prognostic tests of residual disease to assist healthcare professionals in the clinical diagnosis of a patient, to assess the effectiveness of treatments prescribed to patients and change future treatments accordingly; medical and scientific research in the field of treatment and diagnosis of digestive and gastrointestinal diseases and disorders

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 31, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 31, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMAUNA KEA TECHNOLOGIES
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Trademark Events

Event DateEvent Description
Thursday, October 31, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, November 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 1, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, January 8, 2025ASSIGNED TO EXAMINER
Tuesday, March 4, 2025REFUSAL PROCESSED BY MPU
Wednesday, January 15, 2025NON-FINAL ACTION WRITTEN
Thursday, January 16, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 4, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, March 22, 2025REFUSAL PROCESSED BY IB
Tuesday, August 19, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 22, 2025FINAL REFUSAL WRITTEN
Friday, August 22, 2025FINAL REFUSAL E-MAILED
Friday, August 22, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, August 20, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 19, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED

Related Keywords

celltolerance medical services field scientific information diagnostic diagnosis research care health